Clinical Trial Update: Study to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux Esophagitis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety, tolerability, and efficacy of YH4808 in adults with reflux esophagitis; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Reflux Esophagitis

Drugs mentioned

• YH4808

Snippet

Sponsor: Yuhan Corporation | Conditions: Reflux Esophagitis | Phase 2 | Status: COMPLETED